Active Ingredient(s): Betamethasone Dipropionate + Calcipotriene Hydrate
FDA Approved: * January 9, 2006
Pharm Company: * LEO PHARM PRODS
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Taclonex Overview

Calcipotriol/betamethasone dipropionate, sold under the brand name Taclonex among others, is a fixed-dose combination medication of the synthetic vitamin D3 analog calcipotriol (also known as calcipotriene) and the synthetic corticosteroid betamethasone dipropionate for the treatment of plaque psoriasis.[3][4][5] It is used in the form of ointment, topical suspension, gel, aerosol, and foam.[2][3][4 ...

Read more Taclonex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Betamethasone/calcipotriol

Recent Taclonex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Betamethasone Dipropionate + Calcipotriene Hydrate
  • Aerosol, Foam: 0.064% + 0.005%
  • Cream: 0.064% + 0.005%
  • Foam: 0.005% + 0.064%
  • Ointment: 0.064% + 0.005%
  • Suspension: 0.064% + 0.005%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Taclonex: (5 results)

Sorted by National Drug Code
  • 0430-3230 Taclonex Topical Ointment by Warner Chilcott (Us), LLC
  • 50222-227 Taclonex Topical Ointment by Leo Pharma Inc.
  • 50222-499 Taclonex Topical Suspension by Leo Pharma Inc.
  • 50222-501 Taclonex Topical Suspension by Leo Pharma Inc.
  • 54868-5680 Taclonex Topical Ointment by Physicians Total Care, Inc.

Drugs with one or more similar ingredients: (6 results)